Search

18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions.

2 Feb 2022: £1.5m investment via Crowdcube and Cambridge Enterprise creates new jobs and further development of the tech.

9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.

11 Apr 2022: A new class of battery technology. Nyobolt’s team of experts has pioneered a new class of battery technology that achieves record-breaking ultra-fast charging.

23 Nov 2022: a foothold on the ground, who could go in and do preliminary consultations to grasp whether the communities could be interested or not in trying something new.

27 Sep 2022: Early stage innovations are licensed to existing companies for development or spun out as new companies. ... Among these were three companies developing new technologies focused on reducing carbon emissions—and Carbon Re.

9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.

15 Mar 2022: Impact Insight video case study: Kalamna toolkit. The third in our new series of Impact Insight videos focuses on the licensing of the Kalamna toolkit for learning Arabic. ... Dr Khalil has spent her career researching how young Arabic learners can be

12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.

18 Aug 2022: with the potential to provide tens of thousands of new jobs over the next few years.

9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.

11 Apr 2022: Over the past year, the team has identified and reviewed 55 new opportunities and presented 13 to the Ceres Investment Committee.

9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

19 Sep 2022: We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. ... The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both rare genetic diseases as

11 Apr 2022: New Zealand Family Cancer Services. BOADICEA being incorporated within BRRISK helps time-poor GP’s to stratify patients according to risk. ... Oncoplastic Breast Surgeon, Auckland, New Zealand. Pause. Play. If you would like more information on BOADICEA

9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children.

4 Oct 2022: The finalists’ pitches will be judged on a number of criteria, including each business’s competitive position, the potential for new business creation, and each team’s collective skill set.

11 Apr 2022: Evidence included scientific papers, government reports, and local news articles. The close collaboration with local expert teams throughout the process brought great depth of knowledge, and ensured that visions remained focused

9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.

11 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 11 November 2022. Sparxell wins the 2022 Chris Abell Postdoc Business Plan Competition. Share:. Sparxell has won the Chris Abell Postdoc Business Plan Competition 2022, securing the £20